The primary endpoint was the change from baseline in prebronchodilator FEV@ , and secondary endpoints included Asthma Control Questionnaire ( ACQ ) and Standardised Asthma Quality of Life Questionnaire -LSB- AQLQ ( S ) -RSB- , and incidence of exacerbations and respiratory tract infections .